Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Gains from Investment Securities (2016 - 2025)

Chemours (CC) has 12 years of Gains from Investment Securities data on record, last reported at $63.0 million in Q3 2025.

  • For Q3 2025, Gains from Investment Securities rose 950.0% year-over-year to $63.0 million; the TTM value through Sep 2025 reached $88.0 million, up 4300.0%, while the annual FY2024 figure was $98.0 million, 790.91% up from the prior year.
  • Gains from Investment Securities reached $63.0 million in Q3 2025 per CC's latest filing, up from -$16.0 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $89.0 million in Q4 2024 and bottomed at -$48.0 million in Q1 2025.
  • Average Gains from Investment Securities over 5 years is $7.5 million, with a median of $2.0 million recorded in 2022.
  • Peak YoY movement for Gains from Investment Securities: surged 1371.43% in 2024, then tumbled 2500.0% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $11.0 million in 2021, then crashed by 54.55% to $5.0 million in 2022, then crashed by 240.0% to -$7.0 million in 2023, then soared by 1371.43% to $89.0 million in 2024, then fell by 29.21% to $63.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $63.0 million in Q3 2025, -$16.0 million in Q2 2025, and -$48.0 million in Q1 2025.